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Summary
Adipose triglyceride lipase (ATGL)was recently identified as an important triacylglycerol (TG) hydrolase promoting the catab-
olism of stored fat in adipose and nonadipose tissues. We now demonstrate that efficient ATGL enzyme activity requires
activation byCGI-58.Mutations in the humanCGI-58gene are associatedwithChanarin-DorfmanSyndrome (CDS), a rare ge-
netic diseasewhere TGaccumulates excessively inmultiple tissues. CGI-58 interactswithATGL, stimulating its TGhydrolase
activity up to 20-fold. Alleles ofCGI-58 carrying pointmutations associatedwith CDS fail to activate ATGL.Moreover, CGI-58/
ATGLcoexpression attenuates lipid accumulation inCOS-7cells. AntisenseRNA-mediated reductionofCGI-58expression in
3T3-L1 adipocytes inhibits TGmobilization. Finally, expression of functional CGI-58 in CDS fibroblasts restores lipolysis and
reverses the abnormal TG accumulation typical for CDS. These data establish an important biochemical function for CGI-58
in the lipolytic degradation of fat, implicating this lipolysis activator in the pathogenesis of CDS.Introduction
The storage of cellular triacylglycerol (TG) represents a common
strategy in eukarya to fuel constant energy production in a world
of infrequent nutrient supply. In vertebra including humans,
excess nutritional carbohydrates and fat are efficiently con-
verted into TG and deposited in adipose tissue. Functional
energy homeostasis depends on a finely tuned balance of TG
storage and mobilization. Dysfunction of the multifactorial regu-
latory network that links adipose tissue, the digestive tract, and
nervous system via hormones, cytokines, and adipokines (Flier,
2004), disrupts the equilibriumof lipid synthesis and degradation
resulting in prevalent metabolic diseases, such as obesity and
type 2 diabetes (Shulman, 2000; Stumvoll et al., 2005).
Catabolism of TG storage depots andmobilization of free fatty
acids (FFA) in adipocytes andother cell types depend on lipases.
Lipolytic activities in adipose tissue modulate the concentration
of FFA in plasma, which, when chronically elevated, exert a lipo-
toxic effect onmany nonadipose tissues (Schaffer, 2003; Unger,
2002) and contribute to the development of insulin resistance
(Boden and Shulman, 2002). Current models propose that two
lipases are involved in the hydrolysis of TG in adipose and non-
adipose tissues. Theclassical enzyme, hormone-sensitive lipase
(HSL), hydrolyses TG, diglycerides (DG), and monoglycerides
(MG), with the highest specific activity against DG (Belfrage
et al., 1978). b-adrenergic stimulation of adipocytes and the sub-
sequent protein kinase A-dependent phosphorylation of HSL
and perilipin trigger the translocation of HSL from the cytoplasm
to the lipid droplet and induce neutral lipid hydrolysis (Egan et al.,
1992). Yet, studies in HSL-deficient mice showed that the
enzyme is rate limiting in vivo for the catabolism of DG but not
for TG (Haemmerle et al., 2002). Thus, an upstream enzyme in
the lipolytic pathway was predicted and identified, adipose tri-CELL METABOLISM 3, 309–319, MAY 2006 ª2006 ELSEVIER INC. Dglyceride lipase (ATGL) (Zechner et al., 2005; Zimmermann
et al., 2004). ATGL specifically removes the first fatty acid from
the TGmolecule generating FFA andDG. Thedrastic impairment
of fat cell lipolysis inATGL inhibition studies in vitro (Zimmermann
et al., 2004; Smirnova et al., 2006) as well as the nutritional and
insulin dependent regulation of ATGL gene expression in adi-
pose tissue of mice (Villena et al., 2004; Kershaw et al., 2006)
implied a key function for this enzyme in the lipolytic degradation
of stored fat. The importanceof theATGLorthologs inDrosophila
melanogaster (brummer) (Gronke et al., 2005) and Sacharomy-
ces cerevisiae (TGL4) (Kurat et al., 2006) in vivo was reported
recently where deficiency of ATGL led to obese phenotypes.
Human genetic disorders that affect lipolysis due tomutations
in the genes for HSL or ATGL have not been identified. However,
a defect in the lipolytic catabolism of stored TG has been
discussed in association with a rare autosomal recessive inborn
error of neutral lipid metabolism—Chanarin-Dorfman Syndrome
(CDS [MIM 27630]) (Chanarin et al., 1975; Dorfman et al., 1974).
CDS is clinically characterized by ichthyosis, variably accompa-
nied by liver steatosis, cardiomyopathy, ataxia, hearing loss, and
mental retardation. Affected individuals accumulate neutral
lipids in multiple tissues leading to the alternative designation
‘‘neutral lipid storage disease.’’ Lipid accumulation does not re-
sult from increased cellular FFA uptake or TG synthesis rates
(Williams et al., 1988). Instead, it was suggested that a defect
in the catabolism of stored TG underlies the observed pheno-
types (Williams et al., 1991). However, when the gene for com-
parative gene identification, 58 (CGI-58, identical to a/b-hydro-
lase domain-containing protein 5, ABHD5), was identified as
causative for CDS (Lefe`vre et al., 2001), its involvement in neutral
lipid catabolism remained unexplained. CGI-58 belongs to the
esterase/thioesterase/lipase subfamily of proteins structurally
characterized by the presence of a/b-hydrolase folds. TheOI 10.1016/j.cmet.2006.03.005 309
A R T I C L EFigure 1. CGI-58 increases the TG hydrolase activ-
ity in cell and tissue extracts
A)Murine ATGL, HSL, and CGI-58 (CGI) were cloned
into a His-tagged pcDNA4/HisMax expression vec-
tor, and recombinant proteins were expressed in
COS-7 cells. b-galactosidase (LacZ) was used as
a control. His-tagged proteins were detected with
a monoclonal anti-His antibody in Western blotting
experiments using cell extracts (20 mg protein).
B and C) (B) TG hydrolase activity of cell extracts of
transfected cells or (C) of purified His-tagged ATGL
(pATGL, 100 ng/assay), GST-tagged CGI-58 (GST-
CGI, 1 mg/assay), and thrombin-treated purified
CGI-58 (T-CGI, 1 mg/assay) was determined using
a radiolabeled triolein substrate.
D) TG hydrolase activities in cytosolic extracts of
mouse tissues were determined either in the pres-
ence or in the absence of purified GST-CGI
(100 ng/assay).
E) Northern blotting analysis of CGI-58 and ATGL
mRNA expression in various mouse tissues obtained
from fed and fasted mice (SM, skeletal muscle; CM,
cardiac muscle; WAT, white adipose tissue; BAT,
brown adipose tissue). The amount of RNA loaded
onto the blot was visualized using methylene blue
(MB) staining.
Data for TG hydrolase activity assays are presented
as mean 6 SD and represent at least three indepen-
dent experiments (*p < 0.05, **p < 0.01, ***p < 0.001).putative active serine within the canonical esterase/lipase motif
GXSXG is replaced by asparagine in CGI-58 (Lefe`vre et al.,
2001). In adipose tissue, CGI-58 binds to intracellular lipid drop-
lets by interactionwith perilipin (Subramanian et al., 2004; Yama-
guchi et al., 2004). Thedifferent genedefects presently known for
CDS include truncations, deletions, and point mutations imply-
ing a loss of CGI-58 function. The present study is based on
the premise that CGI-58 acts as a TGhydrolase or assists known
TG hydrolases in the lipolytic breakdown of stored fat.
CGI-58 is not a lipase but enhances lipolytic
activity in tissue extracts
The effect of CGI-58 on cellular TG hydrolase activity was tested
in simian virus-40-transformed monkey kidney cells (COS-7)
transfected with cDNA clones expressing His-tagged murine
CGI-58, ATGL, HSL, or b-galactosidase (LacZ).Western blotting
confirmed the expression and the correct molecular mass of the
respective proteins (Figure 1A). In TG hydrolase assays with cell
extracts of transfected cells (Figure 1B), overexpression of
CGI-58 increased the TG hydrolase activity by 1.8-fold com-
pared to LacZ-containing extracts. In comparison, transfection
of cells with ATGL and HSL had a more pronounced effect
and increased TG hydrolase activities by 4- and 9-fold, respec-
tively (Figure 1B).310Purified CGI-58 does not exhibit intrinsic TG hydrolase activ-
ity. A glutathione-S-transferase (GST) CGI-58 fusion protein was
expressed in transformed S. cerevisiae and purified. In contrast
to purified ATGL (pATGL), GST-tagged CGI-58 (GST-CGI) did
not exhibit TG hydrolase activity even after thrombin-mediated
removal of the GST tag (T-CGI) (Figure 1C). However, addition
of GST-CGI to tissue lysates of testis, liver, skeletal muscle, car-
diac muscle, and white or brown adipose tissue increased their
TG hydrolase activity up to 4-fold (Figure 1D).
Northern blotting analysis revealed that CGI-58 is expressed
in virtually all tissues analyzed (Figure 1E). Both CGI-58 mRNA
species,which vary in their 30 untranslated regions (Subramanian
et al., 2004), aremost abundant in testis followed by adipose tis-
sue, liver, and muscle. In comparison, ATGL mRNA levels are
highest in adipose tissue followed by testis, cardiac muscle,
and skeletal muscle. Notably, the activation of lipolysis by exog-
enous CGI-58 inversely correlates with its tissue-specific mRNA
levels, suggesting that in tissuesof lowexpression,CGI-58might
be rate limiting for the lipolytic reaction.
CGI-58 specifically activates ATGL, evidence
for protein-protein interaction
The effect of CGI-58 on the hydrolytic activity of known TG
lipases was analyzed in mixtures of COS-7 cell extractsCELL METABOLISM : MAY 2006
CGI-58 activates ATGL-mediated lipolysisFigure 2. CGI-58 specifically activates TG hydro-
lase activity of ATGL
A) Cell extracts of COS-7 cells expressing ATGL or
HSL were mixed with extracts containing CGI-58
(CGI), LacZ, or purified GST-CGI (100 ng/assay), as
indicated, and TGhydrolase activitywas determined.
B and C) Dose-dependent effect of CGI-58 on ATGL
TG hydrolase activity. Cell extracts containing (B)
murine ATGL or (C) human ATGL were mixed with
increasing amounts of extracts containing murine or
human CGI-58 (hCGI), respectively, and were sub-
jected to TG hydrolase activity assays. The amount
of His-tagged ATGL and CGI-58 were determined
by Western blotting analysis and densitometrical
quantitation.
D) For protein-protein interaction studies, ELISA
plates were coated with GST-CGI or GST and incu-
batedwithCOS-7cell extracts containingHis-tagged
LacZ, HSL, ATGL, or perilipin A (Peri). Binding of
proteins was detected using anti-His primary- and
horseradish peroxidase-conjugated secondary anti-
bodies. The absorbance of the peroxidase reaction
was determined photometrically using tetramethyl-
benzidine as substrate. The absorbance of GST-
coated wells (negative control) was subtracted from
that obtained with GST-CGI.
E) Cell extracts containing ATGL or the ATGLmutant
S47A were mixed with extracts containing CGI-58 or
LacZ, and TG hydrolase activity was determined. TG
hydrolase activity is expressed as fold increase com-
pared to the LacZ control.
All data are presented as mean 6 SD and represent
at least three independent experiments (*p < 0.05,
***p < 0.001).expressingmurineATGLorHSL (Figure 2A). The addition ofCGI-
58 to ATGL-containing extracts enhanced TG hydrolase activity
by 20-fold compared to extracts containing ATGL alone. A com-
parable increase in ATGL activity was observed in the presence
of purified GST-CGI. In contrast, CGI-58 had no effect on the en-
zymatic activity of extracts containing HSL, suggesting that the
substantial activation of TG hydrolysis by CGI-58 was specific
for ATGL. In dose-response experiments,maximal ATGL activity
was achieved at a molar CGI-58/ATGL ratio of 0.5 to 1.0 (Fig-
ure 2B), indicating that the effect of CGI-58 on TG hydrolase
activity is saturable and limited by the amount of ATGL in the
assay system. Human CGI-58 (hCGI) and human ATGL (hATGL)
revealed similar results. As shown in Figure 2C, hCGI increased
the activity of hATGL in a dose-dependent and saturableCELL METABOLISM : MAY 2006manner. In comparison to the mouse ortholog, the magnitude
of themaximal effect on ATGL activation was smaller (4-fold ver-
sus 20-fold) suggesting a quantitative species-dependent differ-
ence in the biological activity of the human and mouse proteins.
Protein-protein interaction between murine CGI-58 and ATGL
was demonstrated in ELISA experiments. Purified GST-CGI was
bound to ELISA plates and incubated with cell extracts con-
taining HSL or ATGL. His-tagged LacZ and perilipin A served
as negative and positive controls, respectively (Subramanian
et al., 2004; Yamaguchi et al., 2004). Compared to LacZ, an
increased bindingwas observed for ATGL and, to a lower extent,
for perilipin A, suggesting a specific interaction of these two
proteins with CGI-58 (Figure 2D). In contrast, HSL did not bind
to GST-CGI above the level of the LacZ control.311
A R T I C L EFigure 3. Effect of CGI-58 on cellular TG metab-
olism
A) COS-7 cells were transfected with LacZ, ATGL,
CGI-58, or both ATGL and CGI-58. Thirty-six hours
after transfection, cellular TG accumulation was
promoted by the addition of oleic acid (0.5 mM).
Cellular TG content was determined at the indicated
time points.
B) Recombinant adenovirus encoding LacZ (LacZ-
Ad), murine ATGL (ATGL-Ad), or murine antisense
ATGL (asATGL-Ad)were used to infect 3T3-L1adipo-
cytes on day 5 of differentiation. Twodays after infec-
tion, the CGI-58 activatable TG hydrolase activity
of cytosolic lysates was determined by incubating
lysates in the absence and presence of various
amounts of purified GST-CGI using radiolabeled
triolein as substrate.
C and D) Release of glycerol (C) and FFA (D) into the
culture medium of 3T3-L1 adipocytes in the absence
(basal) or presenceof 10mMisoproterenol. Cellswere
infected on day 5 of differentiation using adenovirus
encoding LacZ-Ad, asCGI-58-Ad, asATGL-Ad, or
both asATGL-Ad and asCGI-Ad. Two days after in-
fection, adipocytes were incubated in DMEM con-
taining 2% FFA-free BSA for 1 hr, and the release of
glycerol and FFA was determined.
Dataarepresentedasmean6SDand represent three
independent experiments (*p < 0.05, **p < 0.01,
***p < 0.001).To demonstrate that CGI-58-mediated activation of TG hydro-
lysis is based on a functional TG hydrolase activity of ATGL, we
transfected COS-7 cells either with murine wild-type ATGL or an
ATGL construct carrying a single point mutation that expresses
an enzyme with the putative active site serine at position 47
replaced by alanine (S47A). Compared to ATGL-containing cell
extracts, S47A extracts exhibited no measurable TG hydrolase
activity above the level of LacZ transfected cells (Figure 2E).
When cell extracts containing S47A andCGI-58were combined,
no stimulation of TG hydrolysis was observed indicating that the
CGI-58-mediated activation of TG hydrolase activity was de-
pendent on enzymatically functional ATGL.
Modulation of CGI-58 and/or ATGL expression affects
cellular lipolysis and TG storage
In COS-7 cells, endogenous expression of ATGL and CGI-58 is
insufficient to be detected by Northern blotting analysis. There-
fore, these cells were transfected with expression plasmids for
the murine proteins to assess whether CGI-58 and ATGL, singly
or in combination, affect TG accumulation in cells. In culture
medium containing 0.5 mM oleate, the rate of TG accumulation
was identical for cells expressing LacZ, ATGL, andCGI-58 alone
(Figure 3A). In contrast, TG accumulation was drastically re-
duced in cells expressing both ATGL and CGI-58, consistent
with the assumption that CGI-58-mediated activation of ATGL
promotes TG lipolysis thereby lowering TG storage.312The effect of modulating the level of ATGL expression on the
ability of CGI-58 to activate lipolysis was evaluated in adipo-
cytes. Differentiated 3T3-L1 cells were infectedwith an adenovi-
rus encoding murine ATGL (ATGL-Ad) or with an adenovirus en-
coding murine ATGL antisense RNA (asATGL-Ad) (Figure 3B).
Without the addition of CGI-58, the TG hydrolase activity in the
cytosolic cell extracts was similar in cells infected with LacZ
and ATGL-Ad and reduced by 40% when cells were infected
with asATGL-Ad. Upon the addition of increasing amounts of
exogenous CGI-58 to the cell extracts, the highest stimulatory
effect on TG hydrolase activity was obtained in ATGL-Ad in-
fected cells. In contrast, when ATGL expression was silenced
by asATGL-Ad, the CGI-58 inducible TG hydrolase activity was
drastically reduced suggesting that ATGL represents the major
target for CGI-58-mediated activation of lipolysis in adipocytes.
This conclusion was further supported when the effect of low-
ered CGI-58 and/or ATGL expression on glycerol and FFA re-
leasewas studied in 3T3-L1 adipocytes. Infection of 3T3-L1 cells
with asCGI-Ad and asATGL-Ad reduced glycerol release by
46% and 42%, respectively, when lipolysis was induced by iso-
proterenol (Figure 3C). Coinfection of cells with both asCGI-Ad
and asATGL-Ad resulted in a 71% reduction compared to
LacZ-transfected 3T3-L1 adipocytes. Similarly, the FFA release
was reduced by 45%, 46%, and 72%, respectively (Figure 3D).
These data demonstrate that ATGL activation by CGI-58 con-
trols TG mobilization in adipocytes.CELL METABOLISM : MAY 2006
CGI-58 activates ATGL-mediated lipolysisFigure 4. Effect of human CGI-58 (hCGI) andmutant
forms of CGI-58 associated with CDS on human
ATGL (hATGL) TG hydrolase activity
hATGL, wild-type CGI-58, and mutant versions of
hCGI-58 (190TER, Q130P, and E260K) were cloned
into the His-tagged pcDNA4/HisMax expression
vector. Recombinant proteins were expressed in
COS-7 cells.
A) Sequence analysis of cDNAs for hCGI, Q130P,
190TER, and E260K. Nucleotide positions of the mu-
tations are indicated.
B) Cell extracts (20 mg of total protein) were analyzed
for the protein expression of hCGI and all mutant ver-
sions (190TER, Q130P, and E260K) by Western blot-
ting experiments using anti-His antibody.
C) The capacity of mutant forms of hCGI to activate
hATGL was tested in TG hydrolase activity using
combined extracts. hATGL was mixed with hCGI at
a molar ratio of 1:1 based on immunochemical
detection.
Data for TG hydrolase activity assays are presented
as mean 6 SD and represent three independent
experiments (***p < 0.001).Mutations in CGI-58 that are associated
with CDS fail to activate ATGL
Lefe`vre et al. (2001) described eight mutations in the human
CGI-58 gene that are present in nine familieswith a confirmed di-
agnosis of CDS. Of these eight mutations, four were found to be
pointmutations that, in three cases, led to substitution of a single
amino acid. Two of the reported single amino acid variants
(Q130P, E260K) were selected in addition to a novel mutation,
identified in a cDNA clone we generated from the mRNA of
a CDS patient’s skin fibroblasts (Igal et al., 1997). Sequencing
of this mutant CGI-58 cDNA within the coding region revealed
a novel point mutation in nucleotide position 568 (C/ T), which
results in the formation of a premature TAA stop codon and
a truncated protein (190TER). Human mutant cDNAs (Q130P,
E260K) were generated by site-directed mutagenesis of wild-
type CGI-58 or amplified by PCR (190TER) and ligated into the
pcDNA4/HisMaxC expression vector. DNA sequencing con-
firmed the correct nucleotide substitutions (Figure 4A). Wild-
type and mutant hCGI-58 cDNAs were transfected into COS-7
cells andWestern blotting analyses of cell lysates revealed a nor-
mal MW of 39 kDa for hCGI, Q130P, and E260K (Figure 4B). Due
to the premature stop codon, 190TER exhibited aMWof 25 kDa.
In TG hydrolysis assays using combined extracts, wild-type
hCGI increased the enzyme activity of hATGL 4-fold (Figure 4C).
In contrast, all mutant forms of hCGI (190TER, Q130P, and
W260K) added at the same 1:1 molar ratio were unable to stim-CELL METABOLISM : MAY 2006ulate hATGL activity. Thus, mutations in the human CGI-58 gene
with known associations with CDS result in a complete loss of
ATGL-activating function.
Expression of functional CGI-58 normalizes
the TG content in CDS-HSF
The consequences of dysfunctional activation of ATGL by
CGI-58 was assessed by comparing the lipolytic process in nor-
mal human skin fibroblasts (HSF) and fibroblasts from aCDSpa-
tient (CDS-HSF). As described above (Figure 4), theCGI-58 gene
of this patient contains a pointmutation andencodes a truncated
protein (190TER) with complete loss of function. ATGL and
CGI-58 mRNA levels were found to be comparable in both cell
lines (Figure 5A). In an attempt to restore lipolysis, CDS-HSF
were infected with an adenovirus encoding LacZ, functional
CGI-58 (CGI-Ad), or ATGL (ATGL-Ad) (Figure 5B). LacZ infected
CDS-HSF containedw5-fold more TG than HSF. Expression of
functional CGI-58 alone resulted in a 51% reduction of the cellu-
lar TG content in CDS-HSF, whereas overexpression of ATGL
had no effect. Thus, the abnormal accumulation of TG in CDS-
HSF can be reversed by the expression of functional CGI-58.
Functional CGI-58, but not CGI-58 mutants, restores the
reduced lipolytic activity in lipid droplets of CDS-HSF
In accordance with previous studies (Williams et al., 1988), TG
hydrolase activities were identical in lipid-free cytosolic extracts313
A R T I C L Eof CDS-HSF and HSF (Figure 6A), suggesting that the biochem-
ical defect of CDS is associated with the lipid droplet. To inves-
tigate this hypothesis, an in situ lipolysis assay was developed.
We reasoned that since ATGL and CGI-58 are both localized to
cellular lipid droplets (LD) (Liu et al., 2004; Subramanian et al.,
2004; Yamaguchi et al., 2004; Zimmermann et al., 2004), the
extent of activation of ATGL by CGI-58 should be measurable
in LD ‘‘self-digestion’’ experiments and this parameter was
expected to be decreased in LD from CDS-HSF. LD TG were
radioactively labeled by cultivating HSF and CDS-HSF in the
presence of 3H-9,10-oleic acid. After 24 hr, LD were purified by
gradient ultracentrifugation and incubated at 37ºC in the pres-
ence of bovine serum albumin as FFA acceptor. As predicted,
the release of labeled FFA through self-digestion was 66% lower
in LD fromCDS-HSF than in LD from three HSF lines (Figure 6B).
Thus, the LD-associated TG hydrolase activity is markedly
impaired in CDS-HSF.
To assess the effect of exogenously added ATGL and CGI-58
to TG hydrolysis in isolated LD, purified mouse proteins were
added to radiolabeled LD of HSF or CDS-HSF (Figure 6C). The
FFA release from LD of CDS-HSF was significantly lower than
from LD of HSF. Addition of purified GST-CGI increased the re-
lease of FFA to a similar level in LD of both cell types. In contrast,
purified ATGL enhanced the FFA release from HSF more effec-
tively (2.6-fold) than from CDS-HSF, suggesting that ATGL is
not fully active on LD which lack functional CGI-58. Addition of
both GST-CGI and purified ATGL to LD of HSF and CDS-HSF
Figure 5. Expression of functional CGI-58 lowers cellular TG accumulation of
CDS-derived human skin fibroblasts
A) Northern blotting analysis of total RNA from fibroblasts obtained from a CDS
patient (CDS-HSF) and control fibroblasts (HSF). mRNA signal specific for human
ATGL or CGI-58 were obtained with 32P-labeled probes. The amount of RNA
loaded on the blot was visualized with methylene blue (MB).
B) Effect of adenovirus expression of CGI-58 (CGI-Ad) or ATGL (ATGL-Ad)
constructs on TG content of CDS-HSF. For comparison, HSF and CDS-HSF
were infected with an adenovirus expressing LacZ. Cellular TG content was deter-
mined 2 days after infection.
Data are presented as mean 6 SD and represent three independent experiments
(***p < 0.001).314elevated FFA release maximally and to a comparable level.
Essentially, the same results were obtained when cell extracts
containing human CGI-58 and/or human ATGL were incubated
with LD from CDS-HSF or HSF (Figure 6D). In contrast, all
mutant forms of CGI-58 (Q130P, E260K, and 190TER) failed to
induce hATGL-mediated lipolysis in LD from both HSF and
CDS-HSF (Figure 6E).
Discussion
The rate of FFA release from adipose tissue in humans and
rodents is strongly associated with the development of insulin
resistance and type 2 diabetes (Stumvoll et al., 2005), but the
mechanisms and regulation of FFA release from stored fat
remain insufficiently understood (Boden and Shulman, 2002;
Shulman, 2000). The present study provides compelling evi-
dence that CGI-58 is an essential component of the lipolytic
system. CGI-58 potently induces the TG hydrolase activity of
tissue extracts from adipose tissue and muscle. Increased TG
hydrolysis does not result from an intrinsic TG hydrolase activity
of CGI-58, but instead from a striking and specific activation of
ATGL enzyme activity. HSL activity was not affected by CGI-
58. Our findings that overexpression of both ATGL and CGI-58
prevented TG accumulation in COS-7 cells and silencing of
ATGL and/or CGI-58 decreased the lipolytic mobilization of
stored fat in 3T3-L1 adipocytes provided conclusive evidence
that CGI-58 activation of ATGL is physiologically important for
the cellular metabolism of neutral lipids in intact cells.
The interaction of cofactors with lipases and activation of TG
hydrolysis is not uncommon. Well-known examples include
lipoprotein lipase, which requires apolipoprotein CII for optimal
activity (Olivecrona and Beisiegel, 1997; Zdunek et al., 2003)
against chylomicron and VLDL TG, and pancreatic lipase, which
depends on colipase for efficient intestinal digestion of alimen-
tary fat (van Tilbeurgh et al., 1993a; van Tilbeurgh et al.,
1993b). Cofactor–lipase binding increases the hydrophobicity
of the heterodimeric complex, promoting enhanced substrate
binding and efficient enzymatic activity at the water-lipid inter-
phase. ATGL belongs to a new class of lipases containing
a ‘‘patatin-domain’’ commonly found in plant acylhydrolases.
In the absence of protein structure data for both ATGL and
CGI-58, it is difficult to evaluate whether ATGL activation by
CGI-58 follows a similar mechanism as has been observed for
other TG-hydrolases. However, the observed reversible binding
of CGI-58 to LD via perilipin might be of crucial importance in
this context (Subramanian et al., 2004; Yamaguchi et al., 2004).
Mutant forms of CGI-58 that cause CDS (Lefe`vre et al., 2001)
due to single amino acid exchanges or protein truncations are
incapable of activating ATGL. Conversely, when functional
CGI-58 is expressed in CGI-58-defective fibroblasts of patients
with CDS, the abnormal and excessive accumulation of TG is re-
versed. Several previous studies have provided experimental
evidence for a defect in TG hydrolysis or the recycling of acylgly-
cerides to glycerophospholipids in fibroblasts of CDS patients
(Igal and Coleman, 1996; Igal and Coleman, 1998; Williams
et al., 1991). However, the biochemical defect in CDS and the
physiological function of CGI-58 remained unexplained. On
the basis of our observations, we propose that the loss of
ATGL activation by CGI-58 represents an important dysfunction
contributing to the pathogenesis of CDS. Considering the broad
expression pattern of ATGL and CGI-58 in many tissues andCELL METABOLISM : MAY 2006
CGI-58 activates ATGL-mediated lipolysisFigure 6. CDS-HSF exhibit reduced lipid droplet-
associated TG hydrolase activity, which is restored
upon addition of functional CGI-58
A) Cellular TG hydrolase activity of lipid-free cyto-
solic extracts of CDS-HSF and HSF was determined
using a radiolabeled triolein substrate.
B) Lipid droplet-associated TGhydrolase activities of
HSF and CDS-HSF. CDS-HSF and HSFwere labeled
with 3H-9,10-oleate, and radiolabeled LD were
purified by gradient ultracentrifugation. Comparable
TG loading of cells was achieved by incubating
CDS-HSF and HSF in the presence of 0.2 mM and
0.6 mM oleate, respectively. TG hydrolase activity
of isolated droplets with comparable protein and
TG content was assessed by ‘‘self-digestion’’ in the
presence of bovine serum albumin as FFA acceptor.
C) Effect of exogenously added purified mouse
CGI-58 (GST-CGI) and ATGL (pATGL) on FFA mobi-
lization of LD derived from HSF and CDS-HSF. LD
were incubated in the absence (endogenous activity)
or in the presence of GST-CGI or pATGL or in the
presence of both proteins and the FFA release was
determined.
D) Effect of human hATGL- and hCGI-containing
COS-7cell extracts onFFAmobilization of LDderived
from HSF and CDS-HSF. COS-7 cell extracts con-
taining LacZ, hCGI, or mixtures of cell extracts con-
taining hATGL/LacZ or hATGL/hCGI were incubated
with 3H-9,10-oleate-labeled LD, and the FFA release
was determined. Endogenous activity present on LD
was set as blank.
E) Effect of hCGI mutants on hATGL activity using
radiolabeled LD as substrate. Cell extracts of
COS-7 cells expressing hATGL were mixed with ex-
tracts containing LacZ, hCGI, or the mutant versions
of CGI-58 (190TER, Q130P, and E260K) and the FFA
release was determined. The activity of the extract in
the presence of LacZ was arbitrarily set as 1, and the
relative increases of TG hydrolase activity are plotted
on the y axis.
Data are presented as mean 6 SD and represent
three independent experiments (*p < 0.05, **p < 0.01,
***p < 0.001).assuming that ATGL activation by CGI-58 is necessary in all
tissues where the enzyme is found, an activation defect would
result in the observed accumulation of TG in multiple tissues
of CDS patients.
Although ATGL and CGI-58 are coexpressed in many tissues,
the relative mRNA expression levels can be quite different. For
example, in the liver the concentration of CGI-58 mRNA isCELL METABOLISM : MAY 2006high compared to ATGL mRNA, which could not be detected
by Northern blotting analysis. This may indicate that CGI-58
activates additional, presently unidentified lipases. Whether
dysfunction of these putative ATGL-independent mechanisms
also contributes to the clinical heterogeneity in CDS is currently
unknown. However, the striking effects on TG accumulation and
mobilization in response to variation in CGI-58 and ATGL315
A R T I C L Eexpression suggests that, at least in adipocytes, ATGL is the
major target for CGI-58-mediated activation of lipolysis. Thus,
it is conceivable that a subgroup of CDS patients, particularly in-
dividuals where genetic variations in the CGI-58 gene locus are
not found, may be affected with mutations in the gene for ATGL.
In addition to the accumulation of fat, the defective ATGL-me-
diated lipolysis of TG due to insufficient enzyme activation could
also account for the defect in the recycling of glycerolipids into
glycerophospholipids observed in fibroblasts fromCDSpatients
(Igal and Coleman, 1996). The reaction catalyzed by ATGL is
specific for the hydrolysis of the first fatty acid from the TG mol-
ecule and thereby generates DG (Zimmermann et al., 2004). The
subsequent utilization of DG depends on themetabolic status of
the cell. In hormonally stimulated adipocytes under increased
energy demand, DG will be instantly hydrolyzed by HSL to gen-
erate FFA and glycerol as energy substrates. Alternatively, at
times of adequate energy supply, DG can be reesterified to
TG by the DG acyltransferase reaction (Buhman et al., 2001)
within a futile hydrolysis/reesterification cycle, or utilized for
the synthesis of glycerophospholipids as important membrane
constituents. Reduced DG formation due to low ATGL activity
would impair its utilization for glycerophospholipid synthesis
(Igal and Coleman, 1996; Igal and Coleman, 1998).
In conclusion, the activation of ATGL by CGI-58 represents
a novel mechanism involved in the lipolytic breakdown of cellu-
lar lipid depots. Mutations in CGI-58 as observed in patients af-
fected with CDS result in dysfunctional lipolysis and cellular lipid
accumulation. Accordingly, CGI-58 activation of ATGL controls
cellular TG catabolism and may represent the dominant genetic
defect in CDS.
Experimental procedures
cDNA cloning of recombinant His-tagged proteins
The sequences containing the complete open reading frame of mouse ATGL,
HSL, CGI-58, Perilipin A, as well as human ATGL and CGI-58 were amplified
by PCR frommouse or human cDNA using Advantage cDNA Polymerase Mix
(BD Biosciences Clontech, Palo Alto, CA), respectively. cDNA was prepared
from mRNA using SuperScript Reverse Transcriptase protocol (Invitrogen Life
Technologies, Carlsbad, CA). The primerswere designed to create endonucle-
ase cleavage sites (underlined) for subsequent cloning strategies:mouseATGL
forward50-TGGTACCGTTCCCGAGGGAGACCAAGTGGA-30,mouseATGL re-
verse 50-CCTCGAGCGCAAGGCGGGAGGCCAGGT-30, mouse HSL forward
50-TGGTACCTATGGATTTACGCACGATGACACA-30, mouse HSL reverse 50-
CTCGAGCGTTCAGTGGTGCAGCAGGCG-30, mouse CGI-58 forward 50-CG
GATCCAAAGCGATGGCGGCGGAGGA-30, mouse CGI-58 reverse 50-CCTC
GAGTCAGTCTACTGTGTGGCAGATCTCC-30, mouse Perilipin A forward 50-
CGGTACCGTCAATGAACAAGGGCCCAACC-30, mouse Perilipin A reverse
50-CTCTAGATCAGCTCTTCTTGCGCAGCTG-30, human ATGL forward 50-
CGGGATCCTTTCCCCGCGAGAAGACGTG-30, human ATGL reverse 50-CC
CTCGAGCTCACAGCCCCAGGGCCCC-30, human CGI-58 forward: 50-AAG
GTACCAGCGGCGGAGGAGGAGGAG-30, human CGI-58 reverse: 50-CCTC
TAGATCAGTCCACAGTGTCGCAGA-30.
The PCR products were ligated to compatible restriction sites of the eu-
karyotic expression vector pcDNA4/HisMax (Invitrogen Life Technologies).
A control pcDNA4/HisMax vector expressing b-galactosidase was provided
by the manufacturer (Invitrogen Life Technologies).
Cloning of recombinant adenovirus for murine CGI-58
and ATGL expression
For the cloning of mouse ATGL and ATGL-antisense adenovirus con-
structs, a MluI–ClaI flanked cDNA fragment was amplified by PCR from
the cDNA-containing plasmids (described above), using the following
primers: mouse ATGL-Ad forward 50-GCACGCGTCGGACGGCCTCCGA
AACC-30, mouse ATGL-Ad reverse 50-GCATCGATTAGAAGGCACAGTCGA316GGCT-30, mouse antisense ATGL-Ad forward 50-GCATCGATTGGAACAT
CTCATTCGCTGGCT-30, mouse antisense ATGL-Ad reverse 50-GCAC
GCGTGAAGGCCACATTGGTGCAGAAG-30.
Subsequently, the PCR product was ligated to Mlu I–Cla I digested
pAvCvSv34 and the resulting shuttle plasmid was cotransfected with pJM
17 into HEK-293 cells using the calcium phosphate coprecipitation method
(Graham and van der Eb., 1973). Cloning of mouse CGI-58 and CGI-58-anti-
sense adenovirus constructs was performed according to manufacturer’s
instructions using AdEasy XL Adenoviral Vector Sytem (Strategene, La Jolla,
CA). The following primers were used: mouse CGI-58-Ad forward 50-ACCTC
GAGCCACCATGAAAGCGATGGCGGCG-30, mouse CGI-58-Ad reverse 50-A
AAGCTTCTAATGATGATGATGATGATGGTCTACTGTGTGGCAGATCTCC-30,
mouse antisense CGI-58-Ad forward 50-ACAAGCTTCCACCATGAAAGCGAT
GGCGGCG-30, mouse antisense CGI-58-Ad reverse 50-ACTCGAGCTAGTCT
ACTGTGTGGCAGATCTCC-30.
Large-scale production of high-titer recombinant sense and antisense
adenoviruses for ATGL and CGI-58 was performed as described (Teng
et al., 1994). An adenovirus containing b-galactosidase cDNA (LacZ-Ad)
was used as a control.
Generation of site-directed mutagenesis clones
Point mutations were performed by using the GeneTailor Site-Directed
Mutagenesis System (Invitrogen Life Technologies). Mutations in CGI-58
(Q130P, E260K) or ATGL (S47A) were introduced at the positions of the cod-
ing sequences indicated below using the following primer pairs: Q130P:
389A>C forward 50-TGCAGAAGAAGTGGAGAATCCGTTTGTGGAATC
CA-30, Q130P: 389A>C reverse 50-GATTCTCCACTTCTTCTGCATCACTG
TCAAAC-30, E260K: 778G>A forward 50-ATGTGCAGACTCCAAGTGGTAA
GACAGCTTTC-30, E260K: 778G>A reverse 50-ACCACTTGGAGTCTGCA
CATTACAGTGGTAG-30, S47A: 139S>A forward 50-CCACTCACATCTACG
GAGCCGCGGCAGGGGCGCT-30, S47A: 139S>A reverse 50-GGCTCCGT
AGATGTGAGTGGCGTTGGCCAC-30.
Sequence analysis
Sequence analysis of plasmid DNA was performed using the BigDye termi-
nator mixture (Applied Biosystems, Foster City, USA). The PCR products
were sequenced on an ABI PRISM 310 Genetic analyzer (Applied Biosys-
tems, Foster City, CA).
Expression of recombinant proteins and preparation of cell extracts
Monkey embryonic kidney cells (COS-7, ATCC CRL-1651) were transfected
using Metafectene (Biontex GmbH, Munich, Germany) as described
(Zimmermann et al., 2004). For the preparation of cell extracts, cells were
collected by trypsination, washed three times with phosphate buffered saline
(PBS), and disrupted in buffer A (0.25 M sucrose, 1 mM EDTA, 1 mM dithio-
threitol, 20 mg/ml leupetine, 2 mg/ml antipain, 1 mg/ml pepstatin, [pH 7.0]) by
sonication (Virsonic 475, Virtis, Gardiner, NJ). Nuclei and unbroken cells were
removed by centrifugation at 1000 3 g at 4ºC for 5 min. The expression of
the His-tagged proteins was detected using Western blotting analysis as
described (Zimmermann et al., 2004).
Assay for TG hydrolase activity
For the determination of triglyceride hydrolase activity of various recombi-
nant proteins 40 mg protein of respective cell extracts in a total volume of
100 ml buffer A were incubated with 100 ml substrate in a water bath at
37ºC for 60 min. In some cases, recombinant CGI-58 or CGI-58 mutants
expressing extracts (20 mg protein) were first mixed with various recombinant
protein extracts (20 mg protein) in a total volume of 100 ml buffer A and then
incubated with 100 ml substrate. As a control, incubations under identical
conditions were performed with LacZ-expressing lysates alone or mixed
with various recombinant protein lysates. To ensure linearity of the assay
incubation time for reactions with high hydrolytic activities was reduced to
30 or 15 min. Under these conditions in all reactions, less than 10% of the
substrate was hydrolyzed. Determination of TG hydrolase activity in cytosolic
extracts of variousmouse tissues with or without addition of 100 ngGST-CGI
was performed as described (Holm and Osterlund, 1999). After incubation,
the reaction was terminated by adding 3.25 ml of methanol/chloroform/hep-
tane (10:9:7) and 1 ml of 0.1 M potassium carbonate, 0.1 M boric acid,
(pH 10.5). After centrifugation (800 3 g, 15 min), the radioactivity in 1 ml of
the upper phase was determined by liquid scintillation counting. TGCELL METABOLISM : MAY 2006
CGI-58 activates ATGL-mediated lipolysissubstrate was prepared by emulsifying 330 mM triolein (40,000 cpm/nmol)
and 45 mM phosphatidylcholine/phosphatidylinositol (3:1) in 100 mM potas-
sium phosphate buffer, (pH 7.0), and 5% defatted BSA by sonication.
Labeling and isolation of lipid droplets
HSF obtained from control subjects and CDS-HSF were cultured in DMEM
containing 10% FCS. For labeling of TG stores of CDS-HSF, confluent cells
were incubated for 24 hr in the presence of 0.2 mM oleate (4 mCi 3H-9,10-
oleate/mmol), bound to bovine serum albumin (BSA) at a FFA/BSA molar
ratio of 3:1. Comparable TG loading of cells was achieved by incubating
CDS-HSF and control cells in the presence of 0.2 mM and 0.6 mM oleate, re-
spectively. For isolation of lipid droplets (LD), cells were collected by trypsi-
nation andwashed three timeswith PBS. Thereafter, cells were suspended in
buffer A and disrupted by sonication (Virsonic 475, Virtis, Gardiner, NJ). Cell
lysates were transferred to SW41 tubes, overlaid with buffer B (50 mMpotas-
sium phosphate, [pH 7.4], 100 mM KCl, 1 mM EDTA, 20 mg/ml leupetine, 2
mg/ml antipain, 1 mg/ml pepstatin), and centrifuged in a SW41 rotor (Beck-
man, Fullerton, CA) (2 hr, 40.000 rpm, 4ºC). LD were collected as a white
band from the top of the tubes and concentrated by centrifugation (20,000
g, 15 min, 4ºC). The underlying solution was removed and LD were resus-
pended in buffer B by brief sonication. TG and protein contents of LD were
determined using commercial reagents (Thermotrace, Thermo Electron Cor-
poration, Victoria, Australia and Bradford, Biorad Laboratories GmbH, Mu-
nich, Germany, respectively) and were found to be comparable in both prep-
arations (typically w0.5 mg protein/mmol TG for LD of CDS-HSF and HSF).
TLC analysis of LD droplets revealed that more than 95% of the radioactivity
was present in triglycerides.
Assay for TG hydrolase activity using purified lipid
droplets as substrate
To determine LD-associated TG hydrolase activity, 50 ml 3H-9,10-oleate
labeled LD at concentration of 400 mM were diluted with 100 ml buffer A
and 50 ml delipidated BSA (20%, w/v) and incubated for one hour at 37ºC.
The release of FFA was determined as described for TG hydrolase activity
assays. In some cases, the LD were used as substrate for the determination
of TG hydrolase activity in cell extracts or purified proteins.
Accumulation of TG in cultured COS-7 cells expressing various
recombinant proteins
COS-7 cells were transfected with murine recombinant His-tagged ATGL,
CGI-58, or both ATGL and CGI-58, and as a control LacZ using Metafectene
(Biontex GmbH, Munich, Germany) as described (Zimmermann et al., 2004).
After 36 hr, cells were incubated with DMEM containing 10% FCS, antibi-
otics, and 0.5 mM oleate, bound to BSA at a molar ratio of 4:1. After various
times the medium was removed and cellular TG content was determined as
outlined below.
Adenoviral expression of recombinant proteins in cultured cells
Primary cultures of HSF and CDS-HSF and mouse 3T3-L1 cells (ATCC
CL-173) were maintained in Dulbecco’s minimal essential medium (DMEM)
(GIBCO, Invitrogen Corp., Carlsbad, CA) containing 10% fetal calf serum
(FCS) (GIBCO-BRL, Life Technologies, Grand Island, NY) and antibiotics
under standard conditions (37ºC, 5% CO2).
Two days before adenovirus infection, HSF or CDS-HSF were seeded at
a density of 63 104 cells per well (6-well plate). HSF were infected with ade-
novirus constructs expressing murine antisense ATGL (asATGL-Ad) or anti-
sense CGI-58 (asCGI-Ad) and as a control LacZ (LacZ-Ad) with a multiplicity
of infection (MOI) of 1600 pfu/cell in DMEM. CDS-HSF were infected with
adenovirus constructs expressing ATGL (ATGL-Ad) or CGI-58 (CGI-Ad) and
as control LacZ-Ad with a multiplicity of infection (MOI) of 1200 pfu/cell in
DMEM. After 2 hr, DMEM containing 10% FCS and antibiotics were added.
Then fibroblasts were cultured for 48 hr and cellular TG content was
determined as outlined below. Infection efficiency of HSF and CDS-HSF
with adenovirus construct encoding LacZ was determined to bew40%.
3T3-L1 fibroblasts were induced to differentiate into adipocytes 2 days
after confluency, using a standard protocol (Bernlohr et al., 1985). For adeno-
virus expression, 3T3-L1 adipocytes were infected on day 5 of differentiation
with ATGL-Ad, asATGL-Ad, asCGI-Ad, or both asATGL-Ad and asCGI-Ad
with amultiplicity of infection of 1600 pfu/cell. For that purpose, the virus sus-
pension was incubated in DMEM containing 0.5 mg/ml polylysine for 100min.CELL METABOLISM : MAY 2006After addition to the cells and incubation for 24 hr, the medium was removed
and cells were incubated for further 24 hr with DMEM containing 10% FCS.
In control experiments, 3T3-L1 adipocytes were infected with LacZ-Ad.
For determination of FFA and glycerol release, on day 7 of differentiation,
3T3-L1 adipocytes were incubated in DMEM containing 2% fatty acid free
BSA with or without 10 mM isoproterenol at 37ºC. Aliquots of the medium
were collected and the FFA and glycerol content determined as described
below. For the preparation of cytosolic lysates of 3T3-L1 adipocytes, on
day 5 of differentiation, cells were infected either with adenovirus encoding
ATGL-Ad, asATGL-Ad, or as control LacZ-Ad. At day 7 of differentiation, cells
were collected by trypsination, washed three times with PBS, and disrupted
in buffer A by sonication (Virsonic 475, Virtis, Gardiner, NJ). Cytosolic lysates
were obtained by centrifugation at 100,000 3 g for 30 min and subjected to
TG hydrolase assay.
Preparation and purification of GST-tagged CGI-58
The coding sequence ofmouse CGI-58was cloned into pYex4T-1 vector and
transformed into the S. cerevisiae BY4742 [Mata; his3D1; leu2D0; lys2D0;
ura3D0] strain. Large-scale overexpression of GST-CGI was achieved by
maintaining transformed S. cerevisiae carrying in YNB-urea containing 0.5
mM CuSO4 to induce copper promoter-driven expression of the fusion cas-
sette. After induction, cells were harvested and protoplasts were generated
with zymolyase and disrupted by sonication in the presence of 0.2% NP-40.
The supernatant containing the GST-fusion protein was purified using
Glutathione-Sepharose beads (GE Healthcare, Piscataway, NJ). Purified
GST-CGI was dialyzed overnight with 150 mM KCl, 10 mM potassium phos-
phate buffer, (pH 7.4), and 0.01% NP-40.
TALON Co2+ affinity purification of ATGL
COS-7 cells expressing His-tagged mouse ATGL were lysed in buffer C
(25 mM NaPO4, [pH 7.0], 20% glycerol, 2 mM b-mercaptoethanol, 0,01%
NP-40) and incubated with TALON Co2+ resin (BD Biosciences, Palo Alto,
CA). The resin-cell extract suspension was then poured into a micro bio-
spin column (Bio-Rad, Hercules, CA) and washed with 10 column volumes
of buffer C containing 500 mM NaCl. Recombinant His-tagged ATGL was
eluted by a step-gradient of imidazole (200 mM final concentration) in buffer
C. For determination of the purity of the protein, fractions were subjected to
SDS-PAGE gel electrophoresis and Western blotting analysis.
CGI-58 ELISA
For the detection of interacting proteins, ELISA plates (MaxiSorp, Nalge
Nunc Int., Rochester, NY) were coated with 3 mg GST-CGI or GST in buffer
D (50 mM Tris, [pH 8.0], 150mM NaCl, 5 mM CaCl2). The wells were blocked
with 5% BSA in buffer D and incubated with 50 mg protein/well of COS-7 cell
extracts containing His-tagged proteins in 50 mM potassium phosphate
buffer (pH 7.0). After washing with buffer D containing 0.05% Tween 20,
the mouse anti-His antibody (GE Healthcare) was added in the same buffer
containing 0.5% BSA. Subsequent to three further washes, horseradish
peroxidase-conjugated anti-mouse antibody (GE Healthcare) was added.
After washing three times with buffer D containing 0.05% Tween 20, the
absorbance of tetramethyl-benzidine was determined at 450 nm using 620
nm as reference wavelength. The absorbance of GST coated wells was
subtracted from that coated with GST-CGI.
Northern blotting analysis
Total RNA from various mouse tissues or HSF and CDS-HSF cells were
separated by formaldehyde/agarose gel electrophoresis and blotted onto
a Hybond-N+membrane (GE Healthcare). Mouse and human ATGLwere de-
tected with a PstI/XhoI fragment of ATGL and hCGI-58 with the coding region
of CGI-58, labeled with [a-32P]dCTP. Signals were visualized by exposure to
a PhosphorImager Screen (GE Healthcare).
Biochemical analysis
For determination of FFA and glycerol release, 3T3-L1 adipocytes were
incubated in DMEM containing 2% fatty acid free BSA with or without
10 mM isoproterenol at 37ºC. Aliquots of the medium were collected and
the FFA and glycerol content measured with commercial kits (WAKO Chem-
icals GmbH, Neuss, Germany). For the determination of cellular TG content in
COS-7 cells, CDS-HSF or HSF lipids were extracted three times with hexan:
isopropanol (3:2; v/v), brought to dryness, solubilized in 0.1%Trition X-100 by317
A R T I C L Esonication, and TG concentration determined using Infinity Triglycerides
reagent (ThermoElectronCorporation, Victoria, Australia). Protein concentra-
tions of cell extracts and cell homogenates were measured with the Bradford
protein assay (Bio-Rad Laboratories GmbH, Munich, Germany) and BCA
reagent (Pierce Biotechnology, Rockford, IL), respectively, using BSA as
standard.
Statistical analysis
Statistical significance was determined by the Student’s unpaired t test
(two-tailed). Group differences considered significant for p < 0.05 (*),
p < 0.01 (**), and p < 0.001 (***).
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